Biogen Inc. (ETR:IDP)
159.95
-0.70 (-0.44%)
Jan 12, 2026, 11:18 AM CET
Biogen Market Cap
Biogen has a market cap or net worth of €23.66 billion as of January 12, 2026. Its market cap has increased by 13.02% in one year.
Market Cap
23.66B
Enterprise Value
25.92B
Revenue
8.58B
Ranking
n/a
PE Ratio
17.26
Stock Price
€159.95
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 23.66B, an increase of 18,573.94%. That is a compound annual growth rate of 16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 23.66B | 7.61% |
| Dec 31, 2025 | 21.99B | 2.16% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.78B |
| Siemens Healthineers AG | 51.89B |
| Bayer Aktiengesellschaft | 38.20B |
| Fresenius SE & Co. KGaA | 27.73B |
| Sartorius Aktiengesellschaft | 15.77B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |